research A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
Apremilast was not effective in treating moderate-to-severe alopecia areata.



McKinney, TX, United States
Indianapolis, IN, United States
Circoiscrizione II, Italy
Glasgow, United Kingdom
Guaynabo, Puerto Rico
Fort Worth, TX, United States